Granulocyte colony stimulating factor 中文
WebOct 12, 2024 · Methods that do not include the aforementioned tissue engineering components may be at a disadvantage for successful cartilage regeneration. Supported by our in vitro and clinical studies, we propose the use of intraarticular granulocyte colony stimulating factor hG-CSF (IA-hG-CSF) as an adjuvant in cellular interventions in early … WebFilgrastim; Filgrastim-aafi; Filgrastim-sndz; G-CSF ; Granulocyte Colony Stimulating Factor ; Tbo-filgrastim; Pharmacology Indication. Filgrastim is indicated to decrease the incidence of infection‚ as manifested by febrile neutropenia‚ in patients with nonmyeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a significant …
Granulocyte colony stimulating factor 中文
Did you know?
WebFeb 13, 2006 · Granulocyte-macrophage colony-stimulating factor (GM-CSF) is an important hematopoietic growth factor and immune modulator. GM-CSF also has profound effects on the functional activities of various ... WebFeb 15, 2008 · Ten years ago, we reviewed the biologic and molecular effects of recombinant human granulocyte colony-stimulating-factor (rhG-CSF) in healthy individuals. 1 The publication coincided with the onset of the allogeneic peripheral blood progenitor cell (PBPC) transplantation era, made possible by the administration of rhG …
WebContraindication. NEUPOGEN ® is contraindicated in patients with a history of serious allergic reactions to human granulocyte colony-stimulating factors (G-CSFs), such as filgrastim or pegfilgrastim; Splenic Rupture. Splenic rupture, including fatal cases, can occur following the administration of NEUPOGEN ®; Evaluate patients who report left upper … Web目的：研究皮下注射与静脉注射重组人粒细胞刺激因子（recombinant human granulocyte colonystimulating factor,rhG-CSF）注射液两组不同给药途径对急性白血病化学治疗后骨髓抑制期患者的影响。方法：选取保定市第一医院及河北大学附属医院200例急性白血病化学治疗后患者,依据rhG-CSF不同给药途径,分为皮下注射 ...
WebGranulocyte-Macrophage Colony Stimulating Factor (GM-CSF) is secreted by a number of different cell types (including activated T cells, B cells, macrophages, mast cells, endothelial cells and fibroblasts) in response to cytokine … WebColony-stimulating factor: A colony-stimulating factor is a protein that tells your cells what to do. G-CSF can tell an early form of a blood cell (stem cell) to become a …
WebAmong them, granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF) have been demostrated to be …
WebMar 18, 2024 · Granulocyte colony stimulating factor (G-CSF) is a type of drug that doctors prescribe to manage neutropenia, which is the term for a lower-than-normal white blood cell count. People with ... data privacy act ps psbank philippinesWebGranulocyte - colony stimulating factor (G-CSF) is another name for filgrastim. In some cases, health care professionals may use the trade name Neupogen, Granix or Zarxio when referring to the generic drug name filgrastim. Drug type: Filgrastim is a biologic response modifier. It is classified as a colony stimulating factor and a hematopoietic ... data privacy act waiver formWebMar 1, 2006 · Granulocyte colony-stimulating factor is produced naturally by the body and is also available as an injection for patients with low white blood cell counts at risk of … data privacy act research paperbitsgap crypto botWebJun 23, 2024 · The colony-stimulating factors and cancer. Nat Rev Cancer. 2010;10(6):425-434. doi:10.1038/nrc2843. Lyman GH, Allcott K, Garcia J, et al. The effectiveness and safety of same-day versus next-day administration of long-acting granulocyte colony-stimulating factors for the prophylaxis of chemotherapy-induced … bitsgap customer serviceWebAn autopsy case of carcinosarcoma of the liver producing granulocyte-colony stimulating factor (G-CSF) is reported. The patient, a 74-year-old Japanese man, presented with … data privacy act tagalog versionWebG-CSF (Neupogen or Filgrastim), granulocyte-colony stimulating factor, is a glycoprotein that has multiple functions in both physiological and pathophysiological conditions. G … data privacy act sensitive information